Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs01967289
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
PZQ![]() | PRAZIQUANTEL | A | 1GTB | 0.72 | ![]() |
53U![]() | D-phenylalanyl-N-benzyl-L-prolinamide | H,I | 2ZFF | 0.72 | ![]() |
MIN![]() | METHYL-PHE-PRO-AMINO-CYCLOHEXYLGLYCINE | H,I | 1TOM | 0.73 | ![]() |
FD3![]() | N-ALPHA-(2-NAPHTHYLSULFONYL)-3- AMIDINO-L-PHENYLALANINE PIPERAZIDE | A | 1K1L | 0.78 | ![]() |
BM2![]() | S-(R*,R*)]-4-[AMINOIMINOMETHYL)AMINO]- N-[[1-[3-HYDROXY -2-[(2-NAPHTHALENYLSULFONYL)AMINO]- 1-OXOPROPYL]-2-PYRROLIDINYL] METHYL]BUTANAMIDE | H | 1BMM | 0.76 | ![]() |
4MC![]() | (Z)-N-(5-GUANIDINO-1-OXO-1-(5-PHENYL- 1-(PHENYLSULFONYL)PENT-1-EN-3-YLAMINO)PENTAN- 2-YL)-4-METHYLPIPERAZINE-1-CARBOXAMIDE | A,C | 2EFM | 0.74 | ![]() |
998![]() | N-METHYLALANYL-3-METHYLVALYL-N- (1,2,3,4-TETRAHYDRONAPHTHALEN-1- YL)PROLINAMIDE | A | 1TFQ | 0.74 | ![]() |
GSJ![]() | 1-PYRROLIDINEACETAMIDE, 3-[[(6- CHLORO-2-NAPHTHALENYL)SULFONYL]AMINO]- ALPHA-METHYL-N-(1-METHYLETHYL)- N-[2-[(METHYLSULFONYL)AMINO]ETHYL]- 2-OXO-, (ALPHAS,3S)- | A | 2J4I | 0.8 | ![]() |
BSI![]() | 2-(BIPHENYL-4-SULFONYL)-1,2,3,4- TETRAHYDRO-ISOQUINOLINE-3-CARBOXYLIC ACID | A | 1BZS | 0.7 | ![]() |
BSI![]() | 2-(BIPHENYL-4-SULFONYL)-1,2,3,4- TETRAHYDRO-ISOQUINOLINE-3-CARBOXYLIC ACID | A | 1I76 | 0.7 | ![]() |
MIU![]() | N-{(1S)-1-{[4-(3-AMINOPROPYL)PIPERAZIN- 1-YL]CARBONYL}-4-[(DIAMINOMETHYLENE)AMINO]BUTYL}- 3-(TRIFLUOROMETHYL)BENZENESULFONAMIDE | H | 1W7G | 0.76 | ![]() |
NFT![]() | N-(2-AMINOETHYL)-N~2~-{(1S)-1-[4'- (AMINOSULFONYL)BIPHENYL-4-YL]-2,2,2- TRIFLUOROETHYL}-L-LEUCINAMIDE | A | 1VSN | 0.76 | ![]() |
TPR![]() | TOSYL-D-PROLINE | A | 1F4E | 0.72 | ![]() |
MNO![]() | (3S)-N-METHANESULFONYL-3-({1-[N- (2-NAPHTOYL)-L-VALYL]-L-PROLYL}AMINO)- 4-OXOBUTANAMIDE | A | 1BMQ | 0.7 | ![]() |
UKP![]() | [2,4,6-TRIISOPROPYL-PHENYLSULFONYL- L-[3-AMIDINO-PHENYLALANINYL]]-N'- BETA-ALANINYL-PIPERAZINE | A | 1F92 | 0.72 | ![]() |
FD4![]() | N-ALPHA-(2-NAPHTHYLSULFONYL)-N(3- AMIDINO-L-PHENYLALANINYL)-4-ACETYL- PIPERAZINE | A | 1K1M | 0.78 | ![]() |
GVR![]() | (2R)-N-hydroxy-3-naphthalen-2-yl- 2-[(naphthalen-2-ylsulfonyl)amino]propanamide | A,B,C | 2VES | 0.74 | ![]() |
BM9![]() | [S-(R*,R*)]-1-(AMINOIMINOMETHYL)- N-[[1-[N-[(2-NAPHTHALENYLSULFONYL)- L-SERYL]-3-PYRROLIDINYL]METHYL]- 3-PIPERIDENECARBOXAMIDE | H | 1BMN | 0.78 | ![]() |
DI5![]() | AC-(D)PHE-PRO-BOROHOMOORNITHINE- OH | H | 1LHG | 0.71 | ![]() |
FD1![]() | N-ALPHA-(2-NAPHTHYLSULFONYL)-N- (3-AMIDINO-L-PHENYLALANINYL)-D- PIPECOLINIC ACID | A | 1K1I | 0.72 | ![]() |
3CC![]() | N-[(2R)-5-(aminosulfonyl)-2,3-dihydro- 1H-inden-2-yl]-2-propylpentanamide | A | 2QO8 | 0.78 | ![]() |
GSK![]() | 6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL- 2-(4-MORPHOLINYL)-2-OXO ETHYL]- 2-OXO-3-PYRROLIDINYL}-2-NAPHTHALENESULFONAMIDE | A | 2CJI | 0.8 | ![]() |
MID![]() | N==ALPHA==(2-NAPHTHYL-SULFONYL- GLYCYL)-PARA-AMIDINOPHENYL-ALANYL- PIPERIDINE | H | 1DWD | 0.78 | ![]() |
44U![]() | beta-phenyl-D-phenylalanyl-N-propyl- L-prolinamide | B,D | 3DA9 | 0.75 | ![]() |
M25![]() | N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE | A,B | 2NMX | 0.72 | ![]() |
M25![]() | N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE | A | 2NNS | 0.72 | ![]() |
YDP![]() | (3S,4S),-3,4-Bis-[(4-carbamoyl- benzensulfonyl)-(3-methyl-but-2- enyl)-amino]-pyrrolidine | A | 2ZGA | 0.72 | ![]() |
YDP![]() | (3S,4S),-3,4-Bis-[(4-carbamoyl- benzensulfonyl)-(3-methyl-but-2- enyl)-amino]-pyrrolidine | A,B | 3CKT | 0.72 | ![]() |
C1P![]() | N~2~-(MORPHOLIN-4-YLCARBONYL)-N~1~- [(1S,2E)-1-(2-PHENYLETHYL)-3-(PHENYLSULFONYL)PROP- 2-ENYL]-D-LEUCINAMIDE | A,B,C,D | 3BWK | 0.72 | ![]() |
C1P![]() | N~2~-(MORPHOLIN-4-YLCARBONYL)-N~1~- [(1S,2E)-1-(2-PHENYLETHYL)-3-(PHENYLSULFONYL)PROP- 2-ENYL]-D-LEUCINAMIDE | A,B | 1NPZ | 0.72 | ![]() |
008![]() | (S)-2-[(R)-3-AMINO-4-(2-FLUORO- PHENYL)-BUTYRYL]-1,2,3,4-TETRAHYDRO- ISOQUINOLINE-3-CARBOXYLIC ACID AMIDE | A,B,C,D | 2BUC | 0.7 | ![]() |
IZD![]() | ISOTHIAZOLIDINONE ANALOG | A | 2CM7 | 0.76 | ![]() |
SUB![]() | 3-PHENYL-2-{[4-(TOLUENE-4-SULFONYL)- THIOMORPHOLINE-3-CARBONYL]-AMINO}- PROPIONIC ACID ETHYL ESTER | A | 1J4H | 0.71 | ![]() |
730![]() | (S)-3-(3-(4-(2-GUANIDINOETHYL)PIPERIDIN- 1-YL)-2-(NAPHTHALENE-2-SULFONAMIDO)- 3-OXOPROPYL)BENZIMIDAMIDE | A | 2GV6 | 0.74 | ![]() |
FD2![]() | N-ALPHA-(2-NAPHTHYLSULFONYL)-N(3- AMIDINO-L-PHENYLALANINYL)ISOPIPECOLINIC ACID METHYL ESTER | A | 1K1J | 0.73 | ![]() |
TP2![]() | N-[TOSYL-D-PROLINYL]AMINO-ETHANETHIOL | A,B | 1F4D | 0.8 | ![]() |
TP2![]() | N-[TOSYL-D-PROLINYL]AMINO-ETHANETHIOL | A,B | 1F4C | 0.8 | ![]() |
GA0![]() | GLYCYLALANYL-N-2-NAPHTHYL-L-PROLINEAMIDE | A | 2DCM | 0.7 | ![]() |
RA8![]() | N-(BENZYLSULFONYL)-L-LEUCYL-N-(4- {[AMINO(IMINO)METHYL]AMINO}BUTYL)- L-PROLINAMIDE | H,I | 1YPL | 0.72 | ![]() |
D1R![]() | NALPHA-[(4-METHYLPIPERAZIN-1-YL)CARBONYL]- N-{(1S)-3-PHENYL-1-[2-(PHENYLSULFONYL)ETHYL]PROPYL}- L-PHENYLALANINAMIDE | A | 2P7U | 0.73 | ![]() |
D1R![]() | NALPHA-[(4-METHYLPIPERAZIN-1-YL)CARBONYL]- N-{(1S)-3-PHENYL-1-[2-(PHENYLSULFONYL)ETHYL]PROPYL}- L-PHENYLALANINAMIDE | A,C | 2OZ2 | 0.73 | ![]() |
DI4![]() | AC-(D)PHE-PRO-BOROHOMOLYS-OH | H | 1LHF | 0.71 | ![]() |
51U![]() | D-phenylalanyl-N-(3-methylbenzyl)- L-prolinamide | H,I | 2ZF0 | 0.72 | ![]() |
37U![]() | D-phenylalanyl-N-(3-fluorobenzyl)- L-prolinamide | H,I | 2ZDV | 0.7 | ![]() |
F20![]() | N-BENZOYL-L-PHENYLALANYL-4-[(5S)- 1,1-DIOXIDO-3-OXOISOTHIAZOLIDIN- 5-YL]-L-PHENYLALANINAMIDE | A | 2CMA | 0.71 | ![]() |
JNH![]() | 1-[2-(S)-AMINO-3-BIPHENYL-4-YL- PROPIONYL]-PYRROLIDINE-2-(S)-CARBONITRILE | I,J | 2AJL | 0.72 | ![]() |
TST![]() | 4-METHYL-2-{[4-(TOLUENE-4-SULFONYL)- THIOMORPHOLINE-3-CARBONYL]-AMINO}- PENTANOIC ACID | A | 1J4I | 0.7 | ![]() |
DI2![]() | AC-(D)PHE-PRO-BOROLYS-OH | H | 1LHD | 0.71 | ![]() |